Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis Hope S. RugoSusan A. MelinJeff Voigt Review Open access 08 March 2017 Pages: 199 - 205
Basal markers and prognosis in luminal breast cancer Monica J. EngstrømMarit VallaAnna M. Bofin Preclinical study 03 March 2017 Pages: 207 - 217
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients Catherine BinghamSandra V. FernandezR. Katherine Alpaugh Preclinical study Open access 07 March 2017 Pages: 219 - 230
Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing Takehiro YanagawaNaofumi KagaraShinzaburo Noguchi Preclinical study 10 March 2017 Pages: 231 - 240
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women Ling-Ming TsengJen-Hwey ChiuYi-Ming Shyr Preclinical study Open access 15 March 2017 Pages: 241 - 254
Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer Hyung Soon ParkJoohyuk SohnGun Min Kim Clinical trial 27 February 2017 Pages: 255 - 262
Identification of frequent somatic mutations in inflammatory breast cancer Naoko MatsudaBora LimNaoto T. Ueno Clinical Trial 27 February 2017 Pages: 263 - 272
The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance, and the reconstructed breast’s role in intimacy K. RojasM. OnstadJ. Gass Clinical trial 04 March 2017 Pages: 273 - 279
Lymphatico-venous anastomosis as treatment for breast cancer-related lymphedema: a prospective study on quality of life Anouk J. M. CornelissenMelissa KoolShan Shan Qiu Clinical trial Open access 07 March 2017 Pages: 281 - 286
Evaluation of changes to foot shape in females 5 years after mastectomy: a case–control study Iwona Głowacka-MrotekMagdalena SowaWojciech Zegarski Clinical trial Open access 07 March 2017 Pages: 287 - 294
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials M. V. DieciA. FrassoldatiV. Guarneri Clinical trial 13 March 2017 Pages: 295 - 302
Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database Megan C. RobertsDave P. MillerValentina I. Petkov Epidemiology 27 February 2017 Pages: 303 - 310
Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer Teresa M. SalgadoEmily J. DavisN. Lynn Henry Epidemiology 01 March 2017 Pages: 311 - 319
Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities Garth H. RauscherAbigail SilvaKent Hoskins Epidemiology 01 March 2017 Pages: 321 - 330
Health-related quality of life in Black breast cancer survivors with and without triple-negative breast cancer (TNBC) Susan T. VadaparampilJuliette ChristieTuya Pal Epidemiology 03 March 2017 Pages: 331 - 342
Breast cancer screening in patients with cancers other than breast Robin B. LeopoldAlexander W. ThomasClaire F. Verschraegen Epidemiology 06 March 2017 Pages: 343 - 348
Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study Kathleen ConwaySharon N. EdmistonPei Fen Kuan Epidemiology 08 March 2017 Pages: 349 - 361
Estrogen–progestin use and breast cancer characteristics in lean and overweight postmenopausal women Olof J. KjartansdottirLara G. SigurdardottirLaufey Tryggvadottir Epidemiology 09 March 2017 Pages: 363 - 373
Breast cancer subtype distribution is different in normal weight, overweight, and obese women Victoria GershuniYun R. LiJulia Tchou Epidemiology 14 March 2017 Pages: 375 - 381
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients Beth CrawfordSophie B. AdamsLaura van ’t Veer Brief Report Open access 09 March 2017 Pages: 383 - 390
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503) Gretchen G. KimmickBrittny MajorJeanne Mandelblatt Brief Report 10 March 2017 Pages: 391 - 398
Treatment of cutaneous metastases of breast cancer with electrochemotherapy: what is the magnitude of clinical benefit? Luca G. CampanaSara GaluppoSara Valpione Letter to the Editor 08 March 2017 Pages: 399 - 401
Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control M. BourkeD. SodenA. J. P. Clover Rebuttal Letter 17 March 2017 Pages: 403 - 405
Oncoplastic surgery with omental flap reconstruction: a study of 200 cases Alexandre Mendonça MunhozRolf GemperliJosé Roberto Filassi Letter to the Editor 15 March 2017 Pages: 407 - 409
Reply to Munhoz et al. Hisamitsu ZahaNorie AbeMikiko Unesoko Rebuttal Letter 14 March 2017 Pages: 411 - 412
